Suppr超能文献

房颤负担对医疗保健成本和利用的影响。

Impact of Atrial Fibrillation Burden on Health Care Costs and Utilization.

机构信息

Division of Cardiology, Northwestern University, Feinberg School of Medicine, Chicago, Illinois, USA.

Medtronic Inc, Minneapolis, Minnesota, USA.

出版信息

JACC Clin Electrophysiol. 2024 Apr;10(4):718-730. doi: 10.1016/j.jacep.2023.12.011. Epub 2024 Feb 28.

Abstract

BACKGROUND

Integrating patient-specific cardiac implantable electronic device (CIED)-detected atrial fibrillation (AF) burden with measures of health care cost and utilization allows for an accurate assessment of the AF-related impact on health care use.

OBJECTIVES

The goal of this study was to assess the incremental cost of device-recognized AF vs no AF; compare relative costs of paroxysmal atrial fibrillation (pAF), persistent atrial fibrillation (PeAF), and permanent atrial fibrillation (PermAF) AF; and evaluate rates and sources of health care utilization between cohorts.

METHODS

Using the de-identified Optum Clinformatics U.S. claims database (2015-2020) linked with the Medtronic CareLink database, CIED patients were identified who transmitted data ≥6 months postimplantation. Annualized per-patient costs in follow-up were analyzed from insurance claims and adjusted to 2020 U.S. dollars. Costs and rates of health care utilization were compared between patients with no AF and those with device-recognized pAF, PeAF, and PermAF. Analyses were adjusted for geographical region, insurance type, CHADS-VASc score, and implantation year.

RESULTS

Of 21,391 patients (mean age 72.9 ± 10.9 years; 56.3% male) analyzed, 7,798 (36.5%) had device-recognized AF. The incremental annualized increased cost in those with AF was $12,789 ± $161,749 per patient, driven by increased rates of health care encounters, adverse clinical events associated with AF, and AF-specific interventions. Among those with AF, PeAF was associated with the highest cost, driven by increased rates of inpatient and outpatient hospitalization encounters, heart failure hospitalizations, and AF-specific interventions.

CONCLUSIONS

Presence of device-recognized AF was associated with increased health care cost. Among those with AF, patients with PeAF had the highest health care costs. Mechanisms for cost differentials include both disease-specific consequences and physician-directed interventions.

摘要

背景

将患者特定的心脏植入式电子设备(CIED)检测到的心房颤动(AF)负担与医疗保健成本和利用措施相结合,可以准确评估 AF 对医疗保健利用的影响。

目的

本研究的目的是评估设备识别的 AF 与无 AF 的增量成本;比较阵发性心房颤动(pAF)、持续性心房颤动(PeAF)和永久性心房颤动(PermAF)的相对成本;并评估队列之间的医疗保健利用率和来源。

方法

使用去识别的 Optum Clinformatics 美国索赔数据库(2015-2020 年)与美敦力 CareLink 数据库链接,确定在植入后至少 6 个月传输数据的 CIED 患者。从保险索赔中分析了随访期间每位患者的年化成本,并调整为 2020 年的美元。比较了无 AF 和设备识别的 pAF、PeAF 和 PermAF 患者之间的成本和医疗保健利用率。分析调整了地理位置、保险类型、CHADS-VASc 评分和植入年份。

结果

在 21391 名患者(平均年龄 72.9 ± 10.9 岁;56.3%为男性)中,7798 名(36.5%)患者有设备识别的 AF。AF 患者的年化增量成本增加了 12789 美元,每位患者的成本增加了 161749 美元,这是由于医疗保健接触次数增加、与 AF 相关的不良临床事件以及 AF 特异性干预措施所致。在 AF 患者中,PeAF 与最高成本相关,这是由于住院和门诊住院就诊、心力衰竭住院和 AF 特异性干预的发生率增加所致。

结论

设备识别的 AF 的存在与医疗保健成本的增加有关。在 AF 患者中,PeAF 患者的医疗保健费用最高。成本差异的机制包括疾病特异性后果和医生指导的干预措施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验